Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate.

Published on Feb 15, 2017in Oncotarget
· DOI :10.18632/ONCOTARGET.15340
Mohammed A. Butt9
Estimated H-index: 9
(UCL: University College London),
Hayley Pye9
Estimated H-index: 9
(UCL: University College London)
+ 13 AuthorsLaurence Lovat36
Estimated H-index: 36
Sources
Abstract
// Mohammed Adil Butt 1, 2, * , Hayley Pye 1, * , Rehan J. Haidry 2 , Dahmane Oukrif 3 , Saif-U-Rehman Khan 1 , Ignazio Puccio 1 , Michael Gandy 1 , Halla W. Reinert 1 , Ellie Bloom 1 , Mohammed Rashid 4 , Gokhan Yahioglu 5, 6 , Mahendra P. Deonarain 1, 5, 6 , Rifat Hamoudi 1 , Manuel Rodriguez-Justo 3 , Marco R. Novelli 3 , Laurence B. Lovat 1, 2 1 Department for Tissue & Energy, University College London, London, UK 2 Upper Gastrointestinal Service, University College London Hospitals NHS Foundation Trust, London, UK 3 Department of Pathology, University College London, London, UK 4 Department of Oncology, UCL Cancer Institute, London, UK 5 Antikor BioPharma, Stevenage Bioscience Catalyst, Hertfordshire, UK 6 Department of Chemistry, Imperial College London, London, UK * These authors have contributed equally to this work Correspondence to: Mohammed Adil Butt, email: adil.butt@nhs.net Keywords: antibody-drug conjugate, mucins, Barrett’s esophagus, esophageal adenocarcinoma, photodynamic therapy Received: August 11, 2016      Accepted: January 24, 2017      Published: February 15, 2017 ABSTRACT Background: Mucin glycoprotein 1 (MUC1) is a glycosylated transmembrane protein on epithelial cells. We investigate MUC1 as a therapeutic target in Barrett’s epithelium (BE) and esophageal adenocarcinoma (EA) and provide proof of concept for a light based therapy targeting MUC1. Results: MUC1 was present in 21% and 30% of significantly enriched pathways comparing BE and EA to squamous epithelium respectively. MUC1 gene expression was x2.3 and x2.2 higher in BE (p=<0.001) and EA (p=0.03). MUC1 immunohistochemical expression increased during progression to EA and followed tumor invasion. HuHMFG1 based photosensitive antibody drug conjugates (ADC) showed cell internalization, MUC1 selective and light-dependent cytotoxicity (p=0.0006) and superior toxicity over photosensitizer alone (p=0.0022). Methods: Gene set enrichment analysis (GSEA) evaluated pathways during BE and EA development and quantified MUC1 gene expression. Immunohistochemistry and flow cytometry evaluated the anti-MUC1 antibody HuHMFG1 in esophageal cells of varying pathological grade. Confocal microscopy examined HuHMFG1 internalization and HuHMFG1 ADCs were created to deliver a MUC1 targeted phototoxic payload. Conclusions: MUC1 is a promising target in EA. Molecular and light based targeting of MUC1 with a photosensitive ADC is effective in vitro and after development may enable treatment of locoregional tumors endoscopically.
Figures & Tables
Download
📖 Papers frequently viewed together
51 Citations
26 Citations
21 Citations
References63
Newest
#1Hayley Pye (UCL: University College London)H-Index: 9
#2Mohammed A. Butt (UCL: University College London)H-Index: 9
Last. Laurence Lovat (UCL: University College London)H-Index: 36
view all 18 authors...
In many cancers early intervention involves surgical resection of small localised tumour masses. Inadequate resection leads to recurrence whereas overzealous treatment can lead to organ damage. This work describes production of a HER2 targeting antibody Fab fragment dual conjugated to achieve both real time near-infrared fluorescent imaging and photodynamic therapy. The use of fluorescence emission from a NIR-dye could be used to guide resection of tumour bulk, for example during endoscopic diag...
12 CitationsSource
#1Anna Oniszczuk (Medical University of Lublin)H-Index: 15
#2Karolina Wojtunik-Kulesza (Medical University of Lublin)H-Index: 9
Last. Kamila Kasprzak (Medical University of Lublin)H-Index: 7
view all 4 authors...
Abstract Photodynamic therapy (PDT) is an intensively studied part of medicine based on free radicals. These reactive species, extremely harmful for whole human organism, are used for eradication numerous diseases. Specific structure of ill tissues causes accumulation free radicals inside them without attack remaining healthy tissues. A rapid development of medicine and scientific research has led to extension of PDT towards treatment many diseases such as cancer, herpes, acne and based on antim...
85 CitationsSource
#1Phillip R. Stahl (UHH: University of Hamburg)H-Index: 14
#2Carsten Seeschaaf (UHH: University of Hamburg)H-Index: 1
Last. Andreas Marx (UHH: University of Hamburg)H-Index: 25
view all 10 authors...
Background Intra-tumor heterogeneity is a potential cause for failure of targeted therapy in gastric cancer, but the extent of heterogeneity of established (HER2) or potential (EGFR, CCND1) target genes and prognostic gene alterations (MYC) had not been systematically studied.
69 CitationsSource
#1Sritama Nath (UNCC: University of North Carolina at Charlotte)H-Index: 10
#2Pinku Mukherjee (UNCC: University of North Carolina at Charlotte)H-Index: 9
Last. Pinku Mukherjee (UNCC: University of North Carolina at Charlotte)H-Index: 30
view all 2 authors...
The transmembrane glycoprotein Mucin 1 (MUC1) is aberrantly glycosylated and overexpressed in a variety of epithelial cancers, and plays a crucial role in progression of the disease. Tumor-associated MUC1 differs from the MUC1 expressed in normal cells with regard to its biochemical features, cellular distribution, and function. In cancer cells, MUC1 participates in intracellular signal transduction pathways and regulates the expression of its target genes at both the transcriptional and post-tr...
297 CitationsSource
#1Rebecca C. Fitzgerald (University of Cambridge)H-Index: 71
#1Rebecca C Fitzgerald (University of Cambridge)H-Index: 5
Last. John de Caestecker (University of Leicester)H-Index: 11
view all 21 authors...
These guidelines provide a practical and evidence-based resource for the management of patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument was followed to provide a methodological strategy for the guideline development. A systematic review of the literature was performed for English language articles published up until December 2012 in order to address controversial issues in Barrett's oesophagus including ...
768 CitationsSource
#1Rehan Haidry (UCL: University College London)H-Index: 16
#2Jason M. Dunn (UCL: University College London)H-Index: 14
Last. Laurence Lovat (UCL: University College London)H-Index: 36
view all 30 authors...
Background & Aims Patients with Barrett's esophagus (BE) and high-grade dysplasia (HGD) or early neoplasia increasingly receive endoscopic mucosal resection and radiofrequency ablation (RFA) therapy. We analyzed data from a UK registry that follows the outcomes of patients with BE who have undergone RFA for neoplasia. Methods We collected data on 335 patients with BE and neoplasia (72% with HGD, 24% with intramucosal cancer, 4% with low-grade dysplasia [mean age, 69 years; 81% male]), treated at...
169 CitationsSource
#1Mark D. Savellano (Dartmouth College)H-Index: 8
#2Nicci Owusu-Brackett (Dartmouth College)H-Index: 3
Last. Dagmar Högemann Savellano (Dartmouth College)H-Index: 2
view all 6 authors...
A novel pyropheophorbide-a (PPa) derivative, Ac-sPPp, was developed in our lab for targeted photodynamic therapy (PDT) and combination therapies. Its versatile peptide moiety, high water-solubility, amphiphilicity, and micellar aggregation allow efficient coupling to targeting moieties and convenient mixing with other therapeutics. Photosensitizer immunoconjugate (PIC) targeted PDT, using Ac-sPPp conjugated to therapeutic anti-epidermal growth factor receptor (EGFR) antibody cetuximab, and PDT +...
6 CitationsSource
#1Jason M. Dunn (UCL: University College London)H-Index: 14
#2GD Mackenzie (UCL: University College London)H-Index: 8
Last. Laurence Lovat (UCL: University College London)H-Index: 36
view all 12 authors...
Photofrin photodynamic therapy (PDT) is a licenced treatment for Barrett’s oesophagus (BE) with high-grade dysplasia (HGD) but causes strictures and photosensitivity and complete reversal of dysplasia (CR-HGD) by 50 % at 5 years. 5-Aminolaevulinic acid (ALA) is an alternative treatment with non-randomised data suggesting 85 % CR-HGD and a low risk of side effects. We aimed to compare efficacy and side effect profile between the drugs. A single-centre randomised controlled trial was conducted. Pr...
42 CitationsSource
#1Qing Wang (Charité)H-Index: 5
#2Chenming Ma (Charité)H-Index: 2
Last. Wolfgang Kemmner (Charité)H-Index: 25
view all 3 authors...
Background We attempted to identify novel biomarkers and therapeutic targets for esophageal squamous cell carcinoma by gene expression profiling of frozen esophageal squamous carcinoma specimens and examined the functional relevance of a newly discovered marker gene, WDR66.
35 CitationsSource
#1Andrew J. Palmer (Aberd.: University of Aberdeen)H-Index: 5
#2Paul Lochhead (Aberd.: University of Aberdeen)H-Index: 33
Last. Emad M. El-Omar (Aberd.: University of Aberdeen)H-Index: 64
view all 11 authors...
Recently, two large genome-wide association studies, conducted in Chinese populations, have reported associations between upper gastrointestinal cancer and the rs2274223, rs13042395 and rs4072037 polymorphisms in PLCE1, C20orf54 and MUC1, respectively. We aimed to determine whether similar associati
54 CitationsSource
Cited By9
Newest
Aim: analysis of all known markers of proliferation, apoptosis, autophagy and angiogenesis in the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma with the purpose of improvement of diagnostics and treatment quality. Materials and methods. Analysis of the available scientific sources by Russian and foreign authors. Results . Data on all the known markers has been structured and is supposed to be integrated into clinical practice in the diagnosis and treatment of Barrett’s esopha...
Source
#1Deng Pan (Tongji University)H-Index: 2
#2Yubo Tang (CAS: Chinese Academy of Sciences)H-Index: 1
Last. Dapeng Zhou (Tongji University)H-Index: 32
view all 9 authors...
Antibodies targeting aberrantly glycosylated proteins are ineffective in treating cancer. Antibody-drug conjugates have emerged as effective alternatives, facilitating tumor-specific drug delivery. Previous studies have assessed the aberrantly glycosylated tandem repeat region of MUC1 glycoprotein as three site-specific glycosylated neoantigen peptide motifs (PDTR, GSTA, and GVTS) for binding with a monoclonal antibody. This study aimed to develop an antibody-drug conjugate for cancer treatment ...
1 CitationsSource
#1Tian-qiao Huang (Qingdao University)
#2Ya-nan Bi (Qingdao University)
Last. Yi-chuan Huang (Qingdao University)
view all 5 authors...
Mucin 1 (MUC1), a transmembrane glycoprotein, has shown to be as the possible prognostic marker to predict the risk of aggressive head and neck squamous cell carcinoma (HNSCC). In the present study, we investigated the effect of MUC1 in HNSCC cells and the response to X-ray irradiation (IR). Here, we examined the impact of MUC1 overexpression or downexpression on clonogenic survival and apoptosis in response to X-ray irradiation (IR). Radioresistance and radiosensitivity were also observed in HN...
Source
#1D J J M de Gouw (Radboud University Nijmegen)H-Index: 1
#2Mark Rijpkema (Radboud University Nijmegen)H-Index: 49
Last. R. S. van der Post (Radboud University Nijmegen)H-Index: 3
view all 11 authors...
Introduction Tumor-targeted imaging is a promising technique for the detection of lymph node metastases (LNM) and primary tumors. It remains unclear which biomarker is the most suitable target to distinguish malignant from healthy tissue in esophageal adenocarcinoma (EAC).
2 CitationsSource
#1Deng Pan (Tongji University)H-Index: 2
#2Yubo Tang (CAS: Chinese Academy of Sciences)H-Index: 1
Last. Dapeng Zhou (Tongji University)H-Index: 32
view all 9 authors...
Background: Antibodies targeting abnormally glycosylated proteins have been ineffective in treating cancer. Antibody-drug conjugates are emerging as an efficient option, which allow specific delivery of drugs into tumors. We and others have dissected the abnormally glycosylated tandem repeat region of MUC1 glycoprotein as three site-specific glycosylated neoantigen peptide motifs (PDTR, GSTA, GVTS) for monoclonal antibody binding. Methods: Internalization of monoclonal antibodies was studied by ...
Source
#1Runzhi Huang (Zhengzhou University)H-Index: 6
#1Runzhi Huang (Zhengzhou University)
Last. Zongqiang Huang (Zhengzhou University)H-Index: 5
view all 10 authors...
Soft tissue sarcoma (STS) is one of the most challenging tumors for medical oncologists, with a high rate of recurrence after initial resection. In this study, a recurrent STS-specific competitive endogenous RNA (ceRNA) network including seven recurrence and overall survival (OS)-associated genes (LPP-AS2, MUC1, GAB2, hsa-let-7i-5p, hsa-let-7f-5p, hsa-miR-101-3p and hsa-miR-1226-3p) was established based on the gene expression profiling of 259 primary sarcomas and 3 local recurrence samples from...
4 CitationsSource
#1Jalal Taneera (UOS: University of Sharjah)H-Index: 23
#2Sarah Dhaiban (UOS: University of Sharjah)H-Index: 4
Last. Mawieh Hamad (UOS: University of Sharjah)H-Index: 16
view all 9 authors...
Silencing of Chl1 gene expression has been previously reported to reduce insulin secretion. Nevertheless, the mechanism underlying this effect remains unclear. In this study, we performed a serial of studies to investigate how Chl1 affects insulin secretion in INS-1 cells. RNA-sequencing was used to investigate the expression of CHL1 in human adipose, liver, muscle, and human islets. Silencing of Chl1 in INS-1 cells was done to assess its impact on the insulin secretion, content, cell viability,...
1 CitationsSource
#1Sara Fernandes (IST: Instituto Superior Técnico)H-Index: 5
#2Rosa Fernandes (UC: University of Coimbra)H-Index: 28
Last. João P. C. Tomé (IST: Instituto Superior Técnico)H-Index: 52
view all 5 authors...
Photodynamic therapy (PDT) combines a photosensitizer (PS) with the physical energy of non-ionizing light to trigger cell death pathways. PDT has potential as a therapeutic modality to be used in alternative or in combination with other conventional cancer treatment protocols (e.g. surgery, chemotherapy and radiotherapy). Still, due to the lack of specificity of the current PSs to target the tumor cells, several studies have exploited their conjugation with targeting moieties. PSs conjugated wit...
14 CitationsSource
#1Hiroaki Horiuchi (Gunma University)H-Index: 16
#2Atsuki Hirabara (Gunma University)H-Index: 2
Last. Tetsuo Okutsu (Gunma University)H-Index: 8
view all 3 authors...
Abstract The photo-induced side effects of photodynamic therapy of cancer can be suppressed using pH-activatable porphyrin derivatives, which have been developed using an aniline moiety as a pH-responsive quencher. The acid dissociation coefficient of a pH-activatable photosensitizer increased by replacing a dimethylamino with a diethylamino group. Based on this diethylamino derivative, we studied the importance of the intramolecular orthogonal structure between porphyrin and aniline moieties on...
6 CitationsSource